Court Rules
All enforcement actions
Enforcement ActionLow RiskMultistate

NJ AG Sues Uber for Deceptive Subscription Enrollment and Cancellation

Uber Technologies, LLC, and Uber USA, LLCDecember 15, 2025New Jersey Attorney General

Summary

New Jersey Attorney General Matthew Platkin announced that New Jersey is joining a coalition of 22 states in suing Uber for deceptive practices related to its Uber One subscription service. The lawsuit alleges that Uber enrolled consumers without their knowledge and made cancellation extremely difficult, seeking restitution, penalties, and an injunction under New Jersey's Consumer Fraud Act and the Restore Online Shoppers' Confidence Act.

Remedy

The lawsuit seeks restitution for affected consumers, monetary penalties, and an injunction to prohibit Uber from engaging in deceptive enrollment and cancellation practices.

InjunctionConsumer RefundsMonetary Penalty

Contract Impact

In-house legal teams should review customer subscription agreements and terms of service for services like Uber One, focusing on clauses governing auto-renewal, cancellation procedures, enrollment consent, and billing transparency. Ensure these clauses comply with consumer fraud laws such as the New Jersey Consumer Fraud Act and the Restore Online Shoppers' Confidence Act, with clear, conspicuous disclosures to prevent deceptive practices. Changes may be needed to simplify cancellation processes, obtain explicit consent for enrollment, and eliminate hidden or difficult-to-navigate billing terms.

Contract Search Terms

subscription agreementauto-renewal clausecancellation policyenrollment consentbilling practicesdeceptive trade practicesconsumer fraud complianceonline shopper protectionopt-out mechanismclear disclosure

Laws Cited

New Jersey Consumer Fraud ActRestore Online Shoppers’ Confidence Act

Violation Types

Entity Details

Entity

Uber Technologies, LLC, and Uber USA, LLC

Also known as: Uber

Industry

Technology

Multistate Coalition

Maryland Attorney GeneralAlabama Attorney GeneralArizona Attorney GeneralConnecticut Attorney GeneralDistrict of Columbia Attorney GeneralIllinois Attorney GeneralMichigan Attorney GeneralMinnesota Attorney GeneralMissouri Attorney GeneralMontana Attorney GeneralNebraska Attorney GeneralNew Hampshire Attorney GeneralNew York Attorney GeneralNorth Carolina Attorney GeneralOhio Attorney GeneralOklahoma Attorney GeneralPennsylvania Attorney GeneralVirginia Attorney GeneralWest Virginia Attorney GeneralWisconsin Attorney GeneralDistrict Attorney for Alameda CountyFederal Trade Commission

Official Sources

Source Evidence

Entity Name
"Uber Technologies, LLC, and Uber USA, LLC"
Laws Cited
"violations of New Jersey’s Consumer Fraud Act and the federal Restore Online Shoppers’ Confidence Act"
Violation Types
"consumers were enrolled in the service without their knowledge"
Violation Types
"consumers have gone through as many as 23 screens"

Related Enforcement Actions

NJ

Trump Administration

A multistate coalition co-led by New Jersey won a federal court order rejecting the Trump Administration’s decision not to request funding for the CFPB. The order struck down that decision and directed the Administration to follow the law and fund the agency; no monetary penalty or privacy violation is described.

NJ

Mitragynine pseudoindoxyl, MGM-15, and MGM-16

New Jersey’s Attorney General and Division of Consumer Affairs alerted the public that three synthetic kratom-related compounds became illegal to possess or sell in the state under a temporary federal scheduling order. The release describes a controlled-substance alert, not a privacy enforcement action, and identifies no company, privacy violation, or monetary penalty.

NJ

Laboratory Corporation of America Holdings (LabCorp)

$2.3M

Laboratory Corporation of America Holdings agreed to pay $2,287,455 to participating states and strengthen its security and vendor-management practices following an investigation into the 2019 breach at its debt-collection vendor, AMCA. The breach potentially exposed information of more than 27.5 million people nationwide, including sensitive information belonging to approximately 10.2 million LabCorp patients.

NJ

Credit Acceptance Corporation (CAC)

$694.0M

New Jersey's Attorney General and Division of Consumer Affairs, along with 41 Attorneys General, reached a $694 million settlement with subprime auto lender Credit Acceptance Corporation over allegations it originated unaffordable loans its own systems predicted borrowers could not repay, employed aggressive debt-collection tactics, and failed to prevent deceptive vehicle-service contract and GAP product 'packing' by dealers. The multistate settlement stepped in after the CFPB permanently dropped its 2023 enforcement action against CAC in 2025. CAC will provide $60 million in cash restitution, $634 million in debt relief, an additional $15 million to the states, and implement injunctive lending reforms including loan off ramps, pre-loan disclosures, add-on packing safeguards, and a seven-year vehicle price cap. Note: this is a consumer-protection lending enforcement action, not a privacy matter; violation categories are best-fit mappings from the available taxonomy.

NJ

Match Group, Inc.

$650K

The New Jersey Attorney General and Division of Consumer Affairs announced that Match Group, Inc. will pay $650,000 and change its business practices to settle allegations that it misrepresented or failed to disclose its criminal background screening policies and practices to New Jersey users, violating the New Jersey Consumer Fraud Act and the Internet Dating Safety Act. Under a Consent Order, Match must accurately represent its screening policies, notify existing New Jersey members of updated disclosures within 150 days, and post clear and conspicuous disclosures and safety notifications about the limitations of criminal background screenings.

NJ

Glenmark, Lannett, Bausch, Apotex, Heritage, and Emcure

$96.5M

New Jersey and a coalition of states and territories obtained preliminary approval for a plan to distribute funds from settlements with generic drug manufacturers accused of conspiring to raise drug prices. The settlements total approximately $96.5 million, and eligible consumers may submit claims for compensation.